1. Methylcobalamin promotes proliferation and migration and inhibits apoptosis of C2C12 cells via the Erk1/2 signaling pathway
- Author
-
Hideki Yoshikawa, Yusuke Kuroda, Kiyoshi Okada, Tsuyoshi Murase, Shunsuke Nishimoto, Michio Okamoto, and Hiroyuki Tanaka
- Subjects
MAP Kinase Signaling System ,Biophysics ,Apoptosis ,Biochemistry ,Cell Line ,Myoblasts ,Mice ,Cell Movement ,medicine ,Animals ,Myocyte ,Phosphorylation ,Molecular Biology ,PI3K/AKT/mTOR pathway ,Cell Proliferation ,Phosphoinositide 3-kinase ,biology ,Akt/PKB signaling pathway ,Cell Differentiation ,Cell migration ,Cell Biology ,Cell biology ,Vitamin B 12 ,Methylcobalamin ,biology.protein ,Signal transduction ,C2C12 ,medicine.drug - Abstract
Methylcobalamin (MeCbl) is a vitamin B12 analog that has some positive effects on peripheral nervous disorders. Although some previous studies revealed the effects of MeCbl on neurons, its effect on the muscle, which is the final target of motoneuron axons, remains to be elucidated. This study aimed to determine the effect of MeCbl on the muscle. We found that MeCbl promoted the proliferation and migration of C2C12 myoblasts in vitro and that these effects are mediated by the Erk1/2 signaling pathway without affecting the activity of the Akt signaling pathway. We also demonstrated that MeCbl inhibits C2C12 cell apoptosis during differentiation. Our results suggest that MeCbl has beneficial effects on the muscle in vitro. MeCbl administration may provide a novel therapeutic approach for muscle injury or degenerating muscle after denervation.
- Published
- 2014
- Full Text
- View/download PDF